Development of comprehensive disease assessment in systemic vasculitis.

The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical...

Full description

Bibliographic Details
Main Authors: Flossmann, O, Bacon, P, de Groot, K, Jayne, D, Rasmussen, N, Seo, P, Westman, K, Luqmani, R
Format: Journal article
Language:English
Published: 2008
_version_ 1797078954585096192
author Flossmann, O
Bacon, P
de Groot, K
Jayne, D
Rasmussen, N
Seo, P
Westman, K
Luqmani, R
author_facet Flossmann, O
Bacon, P
de Groot, K
Jayne, D
Rasmussen, N
Seo, P
Westman, K
Luqmani, R
author_sort Flossmann, O
collection OXFORD
description The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis requires documentation of disease activity, chronic irreversible damage and impairment of function.
first_indexed 2024-03-07T00:38:48Z
format Journal article
id oxford-uuid:82552013-9e42-4cdc-b309-e403a6983c93
institution University of Oxford
language English
last_indexed 2024-03-07T00:38:48Z
publishDate 2008
record_format dspace
spelling oxford-uuid:82552013-9e42-4cdc-b309-e403a6983c932022-03-26T21:36:37ZDevelopment of comprehensive disease assessment in systemic vasculitis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:82552013-9e42-4cdc-b309-e403a6983c93EnglishSymplectic Elements at Oxford2008Flossmann, OBacon, Pde Groot, KJayne, DRasmussen, NSeo, PWestman, KLuqmani, RThe systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis requires documentation of disease activity, chronic irreversible damage and impairment of function.
spellingShingle Flossmann, O
Bacon, P
de Groot, K
Jayne, D
Rasmussen, N
Seo, P
Westman, K
Luqmani, R
Development of comprehensive disease assessment in systemic vasculitis.
title Development of comprehensive disease assessment in systemic vasculitis.
title_full Development of comprehensive disease assessment in systemic vasculitis.
title_fullStr Development of comprehensive disease assessment in systemic vasculitis.
title_full_unstemmed Development of comprehensive disease assessment in systemic vasculitis.
title_short Development of comprehensive disease assessment in systemic vasculitis.
title_sort development of comprehensive disease assessment in systemic vasculitis
work_keys_str_mv AT flossmanno developmentofcomprehensivediseaseassessmentinsystemicvasculitis
AT baconp developmentofcomprehensivediseaseassessmentinsystemicvasculitis
AT degrootk developmentofcomprehensivediseaseassessmentinsystemicvasculitis
AT jayned developmentofcomprehensivediseaseassessmentinsystemicvasculitis
AT rasmussenn developmentofcomprehensivediseaseassessmentinsystemicvasculitis
AT seop developmentofcomprehensivediseaseassessmentinsystemicvasculitis
AT westmank developmentofcomprehensivediseaseassessmentinsystemicvasculitis
AT luqmanir developmentofcomprehensivediseaseassessmentinsystemicvasculitis